| 000 | 01067 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515041433.0 | ||
| 264 | 0 | _c20060928 | |
| 008 | 200609s 0 0 eng d | ||
| 022 | _a0025-6196 | ||
| 024 | 7 |
_a10.4065/81.9.1225 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJacobson, Terry A | |
| 245 | 0 | 0 |
_aThe safety of aggressive statin therapy: how much can low-density lipoprotein cholesterol be lowered? _h[electronic resource] |
| 260 |
_bMayo Clinic proceedings _cSep 2006 |
||
| 300 |
_a1225-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aHypercholesterolemia _xblood |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 773 | 0 |
_tMayo Clinic proceedings _gvol. 81 _gno. 9 _gp. 1225-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4065/81.9.1225 _zAvailable from publisher's website |
| 999 |
_c16552679 _d16552679 |
||